Over-the-counter non steroidal anti-inflammatory medications: Focus on the management of acute pain

Therapies https://doi.org/10.1016/j.therap.2024.10.061 Ruxandra Burlacu, Venceslas Bourdin, Patrick Blin, Fabrice Camaioni, Béatrice Clairaz, Michel Lantéri-Minet, Françoise Laroche, François Raineri, Serge Perrot, Jean-Paul Stahl, Nicolas H. Thurin, Stéphane Mouly Abstract Non-steroidal anti-inflammatory drugs (NSAIDs) are the second most widely used class of

Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine: A Phase 4, Randomized, Placebo-Controlled Trial

JAMA Neurology 2024 Sep 16:e243043. doi: 10.1001/jamaneurol.2024.3043. Online ahead of print. Stewart J Tepper, David W Dodick, Michel Lanteri-Minet , David Dolezil , Raquel Gil-Gouveia, Christian Lucas, Karolina Piasecka-Stryczynska, Gyöngyi Szabó, Daniel D Mikol, Mahan Chehrenama, Denise E Chou, Yiping Yang, Gabriel Paiva da Silva Lima  Abstract Importance: Patients with chronic migraine and medication

Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care

Cephalalgia 2023 Jun;43(6):3331024231180611.doi: 10.1177/03331024231180611. Aubrey Manack Adams, Dawn C Buse, Elizabeth Leroux, Michel Lanteri-Minet, Fumihiko Sakai, Manjit S Matharu, Zaza Katsarava, Michael L Reed, Kristina Fanning, Katherine Sommer, Richard B Lipton Abstract Background: The Chronic Migraine Epidemiology and Outcomes-International study provides insight into people with migraine in multiple countries. Methods:

Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER study

Cephalalgia 2023 May;43(5):3331024231170807.doi: 10.1177/03331024231170807. Messoud Ashina, Michel Lanteri-Minet, Anders Ettrup, Cecilie Laurberg Christoffersen, Mette Krog Josiassen, Ravinder Phul, Bjørn Sperling, Patricia Pozo-Rosich Abstract Background: Migraine is a disabling neurological disease adversely affecting many aspects of life. Most patients are still required to have failed several older oral

Course of Headaches and Predictive Factors Associated With Analgesia Failure Following Spontaneous Subarachnoid Hemorrhage: A Prospective Cohort Study

Journal of Neurosurgical anesthesiology 2023 Jul 1;35(3):333-337. doi: 10.1097/ANA.0000000000000843. Epub 2022 May 3. Baptiste Bouchier, Geneviève Demarquay, Frédéric Dailler, Anne-Claire Lukaszewicz, Thomas Ritzenthaler Abstract Background: Headache is the most common presenting symptom of spontaneous subarachnoid hemorrhage and managing this acute pain can be challenging.

Frontal headache in a patient with right temporal epilepsy: A video-EEG case report of ictal epileptic headache

Headache 2023 Mar;63(3):455-458.doi: 10.1111/head.14475. Epub 2023 Mar 10. Geneviève Demarquay, Emilie Sala, Ahmed Adham, Jean-Philippe Camdessanché, Philippe Convers, Laure Mazzola Abstract Background: Ictal epileptic headache (IEH) is caused by a focal epileptic seizure. The diagnosis can be challenging when the headache is isolated without any